Myosana Therapeutics is a new biotech company developing novel platform technology for non-viral gene delivery.
Myosana Therapeutics is a new biotech company developing novel platform technology for non-viral gene delivery. Myosana Therapeutics has developed a non-viral gene delivery platform technology that specifically targets muscle cells to produce the missing protein caused by a mutation of a gene.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 23, 2020 | Seed | $1M | 1 | CureDuchenne Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
CureDuchenne Ventures | Yes | Seed |